StockData
Cadrenal Therapeutics, Inc. logo

Cadrenal Therapeutics, Inc. (CVKD) stock

CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/30
$1.72−0.16 (-8.51%)

Close on Nov 18, 2026Market cap $6.14MP/E –Yield 959.30%

Cadrenal Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cadrenal Therapeutics's market cap was $4.49M on Nov 11, 2026, against $19.34M a year earlier. Over the last 4 years it ranged from $3.05M to $33.87M, with a median of $13.97M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.49M-67.8%
2025Dec 31, 2025$13.97M-21.9%
2024Dec 31, 2024$17.89M+85.7%
2023Dec 29, 2023$9.64M–

More Cadrenal Therapeutics figures

See a number that looks wrong?